AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Jeremy Richard Brozyna
Public Documents
1
March 25, 2025
Efficacy and safety of omalizumab for tolerating refractory carboplatin desensitizati...
Jeremy Richard Brozyna, Reena Patel, William Bradford Fancher, et al.